Prognose

Vi har ingen analytikerdata for denne virksomhed.

Nyheder Til nyhedsfeedet

CodeLab Capital reports strong Q2 growth, shares rise 7.8%

CodeLab Capital increased ARR by 53% to NOK 52m and raised the share of recurring revenues to 74% of sales; Q2 revenue was NOK 17.7m. Cash-EBITDA was slightly negative at -NOK 1m, but Kuba generated positive cash flow before growth investments. The acquisition of Agil Helse added around 1,500 customers and is expected to contribute NOK 20–25m annually; ARR visibility is about NOK 70m. After the results the stock climbed 7.82% and management signals further M&A activity with several target candidates. » Mere på de.investing.com

I 2023 har Codelab Capital allerede udloddet 10,65 € i udbytte. Den seneste udlodning fandt sted i maj 2023.

I det seneste kvartal havde Codelab Capital en omsætning på 954,41 t € og et nettoresultat på -361,52 t €